Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Teva
Baxter
US Department of Justice
Federal Trade Commission
Argus Health
US Army
UBS
Colorcon

Generated: December 13, 2018

DrugPatentWatch Database Preview

Wyeth Ayerst Company Profile

« Back to Dashboard

What is the competitive landscape for WYETH AYERST, and what generic and branded alternatives to WYETH AYERST drugs are available?

WYETH AYERST has eighty-two approved drugs.



Summary for Wyeth Ayerst
US Patents:0
Tradenames:64
Ingredients:56
NDAs:82

Drugs and US Patents for Wyeth Ayerst

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst ROBITET tetracycline hydrochloride CAPSULE;ORAL 061734-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst PLEGINE phendimetrazine tartrate TABLET;ORAL 012248-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 080554-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst GRISACTIN ULTRA griseofulvin, ultramicrocrystalline TABLET;ORAL 062438-002 Nov 17, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst MEPERIDINE AND ATROPINE SULFATE atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 085121-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Wyeth Ayerst

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst PEPTAVLON pentagastrin INJECTABLE;INJECTION 017048-001 Approved Prior to Jan 1, 1982 3,896,103 ➤ Try a Free Trial
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-003 Sep 7, 1982 3,658,993 ➤ Try a Free Trial
Wyeth Ayerst PMB 400 estrogens, conjugated; meprobamate TABLET;ORAL 010971-003 Approved Prior to Jan 1, 1982 5,210,081 ➤ Try a Free Trial
Wyeth Ayerst INDERIDE LA 120/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-002 Jul 3, 1985 4,138,475 ➤ Try a Free Trial
Wyeth Ayerst INDERAL propranolol hydrochloride SUSPENSION;ORAL 019536-001 Dec 12, 1986 4,600,708 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Dow
Fuji
Cantor Fitzgerald
Citi
Daiichi Sankyo
US Army
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.